Literature DB >> 22718438

Short pain-provoked head-up tilt test for the confirmation of vasovagal syncope.

Ivan Adamec1, Antonija Mišmaš, Dinka Zaper, Anamari Junaković, Sanja Hajnšek, Mario Habek.   

Abstract

We investigated a short pain-provoked head-up tilt (PP-HUT) and the Calgary Syncope Symptom Score in a group of patients with clinically diagnosed vasovagal syncope and group of neurological patients without transient loss of consciousness. We included 127 consecutive patients who were investigated in our laboratory. The group 1 included 56 patients who after appropriate investigations were diagnosed with vasovagal syncope. The group 2 included 70 neurological patients without transient loss of consciousness. The subjects were tilted to 70° for a maximum period of 10 min or until symptoms occurred. If there were no symptoms after initial 10 min, a painful stimulus with the insertion of 0.7 mm needle into the dorsum of hand subcutaneously for 30 s was performed with the patient in the tilted for further 5 min. Calgary Syncope Symptom Score was calculated for all patients. In the group 1, significantly higher number of patients had positive results on PP-HUT (36 vs. 6 patients, respectively; p < 0,001). There was no difference in the presence of orthostatic hypotension (8 vs. 15 patients, respectively; p = 0.36) or postural orthostatic tachycardia syndrome (3 vs. 1 patient, respectively; p = 0.32) between groups. PP-HUT had sensitivity of 65.9 % (95 % CI 0.49-0.79) and specificity of 89.7 % (95 % CI 0.75-0.97). The CSSS had sensitivity of 58.5 % (95 % CI 0.42-0.73) and specificity of 46.1 % (95 % CI 0.30-0.63). PP-HUT has a higher diagnostic rate than the CSSS and provides a rapid alternative to conventional methods.

Entities:  

Mesh:

Year:  2012        PMID: 22718438     DOI: 10.1007/s10072-012-1138-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  19 in total

Review 1.  Hypothalamic and midbrain circuitry that distinguishes between escapable and inescapable pain.

Authors:  Bridget M Lumb
Journal:  News Physiol Sci       Date:  2004-02

2.  Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary.

Authors:  Michele Brignole; Paolo Alboni; David G Benditt; Lennart Bergfeldt; Jean-Jacques Blanc; Poul Erik Bloch Thomsen; J Gert van Dijk; Adam Fitzpatrick; Stefan Hohnloser; Jan Janousek; Wishwa Kapoor; Rose Anne Kenny; Piotr Kulakowski; Giulio Masotti; Angel Moya; Antonio Raviele; Richard Sutton; George Theodorakis; Andrea Ungar; Wouter Wieling; Silvia G Priori; Maria Angeles Alonso Garcia; Andrzej Budaj; Martin Cowie; Jaap Deckers; Enrique Fernandez Burgos; John Lekakis; Bertil Lindhal; Gianfranco Mazzotta; João Morais; Ali Oto; Otto Smiseth; Carlo Menozzi; Hugo Ector; Panos Vardas
Journal:  Eur Heart J       Date:  2004-11       Impact factor: 29.983

Review 3.  Clinical practice. Neurocardiogenic syncope.

Authors:  Blair P Grubb
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

4.  Diagnostic criteria for vasovagal syncope based on a quantitative history.

Authors:  Robert Sheldon; Sarah Rose; Stuart Connolly; Debbie Ritchie; Mary-Lou Koshman; Michael Frenneaux
Journal:  Eur Heart J       Date:  2005-10-13       Impact factor: 29.983

5.  Is vasovagal syncope a disease?

Authors:  Paolo Alboni; Michele Brignole; Ettore C Degli Uberti
Journal:  Europace       Date:  2007-02       Impact factor: 5.214

6.  Value of sublingual isosorbide dinitrate before isoproterenol tilt test for diagnosis of neurally mediated syncope.

Authors:  C Zeng; Z Zhu; W Hu; G Liu; S Zhu; Y Zhou; W Shi
Journal:  Am J Cardiol       Date:  1999-04-01       Impact factor: 2.778

7.  Safety and tolerability of an aggressive tilt table test protocol in the evaluation of patients with suspected neurocardiogenic syncope.

Authors:  S C Vlay; C Brodsky; L C Vlay
Journal:  Pacing Clin Electrophysiol       Date:  2000-04       Impact factor: 1.976

8.  Two-year morbidity and mortality in elderly patients with syncope.

Authors:  Andrea Ungar; Gianluigi Galizia; Alessandro Morrione; Chiara Mussi; Gabriele Noro; Loredana Ghirelli; Giulio Masotti; Franco Rengo; Niccolò Marchionni; Pasquale Abete
Journal:  Age Ageing       Date:  2011-09-09       Impact factor: 10.668

9.  Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope.

Authors:  A Del Rosso; P Bartoli; A Bartoletti; A Brandinelli-Geri; F Bonechi; M Maioli; F Mazza; A Michelucci; L Russo; E Salvetti; M Sansoni; A Zipoli; A Fierro; A Ieri
Journal:  Am Heart J       Date:  1998-04       Impact factor: 4.749

10.  Diagnosing vasovagal syncope based on quantitative history-taking: validation of the Calgary Syncope Symptom Score.

Authors:  Jacobus J C M Romme; Nynke van Dijk; Kimberly R Boer; Patrick M M Bossuyt; Wouter Wieling; Johannes B Reitsma
Journal:  Eur Heart J       Date:  2009-08-17       Impact factor: 29.983

View more
  3 in total

Review 1.  Tilt table testing for syncope and collapse.

Authors:  Ritsuko Kohno; Wayne O Adkisson; David G Benditt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-04-25

2.  Comparison of pain-provoked versus standard 40-min tilt table test for the conformation of vasovagal syncope.

Authors:  Ivan Adamec; Anamari Junaković; Magdalena Krbot Skorić; Mario Habek
Journal:  Neurol Sci       Date:  2022-04-21       Impact factor: 3.830

3.  Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting.

Authors:  Berislav Ruška; Tin Pavičić; Ivan Pavlović; Anamari Junaković; Ivan Adamec; Luka Crnošija; Magdalena Krbot Skorić; Mario Habek
Journal:  Neurol Sci       Date:  2018-08-23       Impact factor: 3.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.